/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Cardio Diagnostics Holdings Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$2.93 -0.0069(-0.69%) CDIO at 04 Dec 2025 04:28 PM Biotechnology
Lowest Today 2.87
Highest Today 2.88
Today’s Open 2.88
Prev. Close 2.9
52 Week High 53.10
52 Week Low 2.42
Day’s Range: Low 2.87 High 2.88
52-Week Range: Low 2.42 High 53.10
1 day return -
1 Week return -
1 month return -17.71
3 month return -16.8
6 month return -37.34
1 year return +920.27
3 year return +39.81
5 year return -
10 year return -

Institutional Holdings

BlackRock Inc 2.02

Vanguard Institutional Extnd Mkt Idx Tr 1.14

Geode Capital Management, LLC 0.76

Susquehanna International Group, LLP 0.74

Vanguard Group Inc 0.72

Fidelity Extended Market Index 0.47

Royal Bank of Canada 0.43

Fidelity Total Market Index 0.13

Fidelity Series Total Market Index 0.11

Spartan Extended Market Index Pool F 0.08

PNC Financial Services Group Inc 0.08

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

Spartan Total Market Index Pool G 0.05

Extended Equity Market Fund K 0.04

UBS Group AG 0.04

Fidelity Nasdaq Composite Index 0.02

NT Ext Equity Mkt Idx Fd - NL 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

NT Ext Eq Mkt Indx Fd DC Lend T3 0.02

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Advisor Group Holdings, Inc. 0.01

Wolverine Asset Management LLC 0.01

Morgan Stanley - Brokerage Accounts 0.01

Tower Research Capital LLC 0.01

Extended Equity Market Fund M 0.01

SBI Securities Co Ltd 0.00

Northern Trust Wilshire 5000 0.00

Bank of America Corp 0.00

SRS Capital Advisors Inc 0.00

FMR Inc 0.00

Citigroup Inc 0.00

Endowment Wealth Management, Inc. 0.00

LPL Financial Corp 0.00

Millennium Management LLC 0.00

Scientech Research LLC 0.00

Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 5.30 M

PB Ratio 0.6452

PE Ratio 0.0

Enterprise Value -0.61 M

Total Assets 10.62 M

Volume 21644

Company Financials

Annual Revenue FY23:12705 0.0M, FY22:950 0.0M, FY21:901 0.0M, FY20:0 0.0M

Annual Profit FY23:null 0.0M, FY22:950 0.0M, FY21:901 0.0M, FY20:null 0.0M

Annual Net worth FY23:-9365962 -9.4M, FY22:-4660985 -4.7M, FY21:-620448 -0.6M, FY20:-605164 -0.6M

Quarterly Revenue Q3/2025:2855 0.0M, Q2/2025:7475 0.0M, Q1/2025:940 0.0M, Q3/2024:6580 0.0M, Q2/2024:7870 0.0M

Quarterly Profit Q3/2025:-86733 -0.1M, Q2/2025:-81668 -0.1M, Q1/2025:940 0.0M, Q3/2024:6580 0.0M, Q2/2024:-32916 -0.0M

Quarterly Net worth Q3/2025:-1714536 -1.7M, Q2/2025:-1683199 -1.7M, Q1/2025:-1635064 -1.6M, Q3/2024:-1412566 -1.4M, Q2/2024:-1287995 -1.3M

Fund house & investment objective

Company Information Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Dr. Meeshanthini V. Dogan Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow